Journal of Diabetes Investigation

Article	Citations
	99
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM‐Japan study	93
Effects of high‐intensity interval walking training on muscle strength, walking ability, and health‐related quality of life in people with diabetes accompanied by lower extremity weakness: A randomize	68
High‐density lipoprotein in diabetes: Structural and functional relevance	56
Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes	51
Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs	47
Effect of glucagon‐like peptide‐1 receptor agonists on fat distribution in patients with type 2 diabetes: A systematic review and meta‐analysis	46
Tracing the molecular landscape of diabetic nephropathy: Insights from machine learning and experiment verification	45
Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks	42
Non‐laboratory‐based risk assessment model for case detection of diabetes mellitus and pre‐diabetes in primary care	41
Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study	39
Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real‐world clinical practice: 36 month post‐marketing observational study	37
Relationship between diabetes treatment status and occupational accidents	35
HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019	35
Can we catch the second loach employing BACE1 inhibition, even as the first one might be escaping?	33
Uhrf1 downregulation promotes β‐cell dedifferentiation by decreasing Foxo1 expression in type 2 diabetes	31
Impact of the COVID‐19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study	30
Graft failure after allogeneic islet transplantation in a patient with type 1 diabetes and a high anti‐glutamic acid decarboxylase antibody titer	30
Unmet needs in current clinical practice for insulinoma: Lessons from nationwide studies in Japan	30
Issue Information	29
LGR signaling and metabolic regulation: A new frontier in addressing insulin resistance and diabetes treatment	28
Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity	27
Association between equol producers and type 2 diabetes mellitus among Japanese older adults	27
Precision medicine in diabetes prediction: Exploring a subgroup‐specific biomarker strategy for risk stratification	26
Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges	26

Differences in cause of death and age at death between people with and without diabetes over 10 years (2010–2020): A cross‐sectional study in Japan	26
Substitution of telemedicine for clinic visit during the COVID‐19 pandemic of 2020: Comparison of telemedicine and clinic visit	24
Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials	24
Long‐term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits	23
Commentary on “Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prosp	23
Stimulatory effect of imeglimin on incretin secretion	23
LX9211, a rising star for relieving of diabetic peripheral neuropathic pain	23
Construction of a metabolic‐immune model for predicting the risk of diabetic nephropathy and study of gut microbiota	22
Letter to the Editor in Response to “Association between severity of diabetic complications and risk of cancer in middle‐aged patients with type 2 diabetes”	22
Is a low‐carbohydrate, high‐fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?	21
Trends in incidence rates of childhood type 1 diabetes mellitus: A retrospective study in Isfahan province, Iran	21
Resistin G–A haplotype at SNP‐420/‐358 is associated with the latent sarcopenic obesity index in the toon genome study	21
Association of cardiovascular health metrics with annual incidence of prediabetes or diabetes: Analysis of a nationwide real‐world database	21
Glycemic metrics in Japanese isCGM users – Analysis by diabetes type and therapy	20
An update of contemporary insulin therapy	20
Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus	20
Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes	19
Updates for hyperglycemia in pregnancy: The ongoing journey for maternal–neonatal health	19
The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus	19
Measuring the foveal avascular zone in diabetes: A study using optical coherence tomography angiography	18
Gastric filling ultrasound in assessing gastrointestinal motility in type 2 diabetic patients with neuropathy: A clinical study	18
A unique profile of insulin antibody titer in islet‐transplanted patients	18
Young‐onset diabetes patients in Thailand: Data from Thai Type 1 Diabetes and Diabetes diagnosed Age before 30 years Registry, Care and Network (T1DDAR CN)	18
Trained immunity: A key player of “metabolic memory” in diabetes	17
Letter to the Editor in response to the article “Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes”	17
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)	17
The causal relationship between gestational diabetes mellitus and postpartum depression: A Mendelian randomization study	17
Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region	17
	16
Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021	16
Diabetes care in China: Innovations and implications	16
Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes	16
Fermented soybean foods and diabetes	16
miR‐130a‐3p enhances autophagy through the YY1/PI3K/AKT/mTOR signaling pathway to regulate macrophage polarization and alleviate diabetic retinop	16
Precision medicine in diabetes: A non‐invasive prenatal diagnostic test for the determination of fetal glucokinase mutations	15
Machine learning for the prediction of atherosclerotic cardiovascular disease during 3‐year follow up in Chinese type 2 diabetes mellitus patients	15
Neuronal regulation of glucagon secretion and gluconeogenesis	15
Association of leukocyte counts in the first trimester with glucose intolerance during pregnancy	15
Long non‐coding ribonucleic acid ATP2B1‐AS1 modulates endothelial permeability through regulating the miR‐4729–IQGAP2 axis in diabetic retinopathy	15
Using recombinase‐mediated cassette exchange to engineer MIN6 insulin‐secreting cells based on a newly identified safe harbor locus	15
Impact of COVID‐19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study	14
Validation using item response theory, and assessment of sensitivity to change of the Hypoglycemia Awareness Questionnaire in patients with type 2 diabetes treated with insulin	14
C1q tumor necrosis factor‐related protein 4 is associated with coronary artery disease in patients with type 2 diabetes	14
Deterioration in ankle reflex is associated with a reduced estimated glomerular filtration rate in patients with type 2 diabetes: A retrospective observational cohort study	14
Diabetes mellitus impacts on expression of DNA mismatch repair protein PMS2 and tumor microenvironment in pancreatic ductal adenocarcinoma	14
Issue Information	14
Comparative effects of fixed‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled	13
MiR‐488‐3p facilitates wound healing through CYP1B1‐mediated Wnt/β‐catenin signaling pathway by targeting MeCP2	13
Dipeptidyl peptidase‐4 inhibitor and insulin combination treatment in type 2 diabetes and chronic kidney disease: A meta‐analysis	13
Issue Information	13

Effect of sodium–glucose cotransporter 2 inhibitor medication on new prescriptions of antihypertensives, antigout/antihyperuricemics and antidyslipidemics in Japan: Analysis using the JMDC	13
Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan	13
Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations	13
Toward a cure for diabetes: iPSC and ESC‐derived islet cell transplantation trials	13
Associations of age‐adjusted coefficient of variation of R‐R intervals with autonomic and peripheral nerve function in non‐elderly persons with diabetes	13
Circulating selenoprotein P levels predict glucose‐lowering and insulinotropic effects of metformin, but not alogliptin: A post‐hoc analysis	12
Erratum	12
Role of glycosylphosphatidylinositol‐anchored high‐density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes	12
miR‐92a aggravates metabolic syndrome via KLF2/miR‐483 axis	12
Contribution of animal models to diabetes research: Its history, significance, and translation to humans	12
Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks	12
Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes	12
Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies	12
The association between alcohol drinking and glycemic management among people with type 2 diabetes in China	12
Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS	12
LncRNA TCF7 contributes to high glucose‐induced damage in human podocytes by up‐regulating SEMA3Avia sponging miR‐16‐5p	12
Awareness of the risk factors and interventions for dementia among outpatients with diabetes	12
	11
Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study	11
Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals	11
Improvement of hepatic steatosis and fibrosis in diabetes: Which bariatric procedure is more appropriate?	11
Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: A systematic review and meta‐analysis	11
Effects of hybrid closed‐loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor‐augmented pump: A prospective single‐center observational study	11
Recent updates to understand the heterogeneity of type 2 diabetes mellitus	11
Sleep duration and food intake in people with type 2 diabetes mellitus and factors affecting confectionery intake	11
The era of continuous glucose monitoring and its expanded role in type 2 diabetes	11
Point‐of‐care sural nerve conduction could predict the presence of cardiovascular autonomic neuropathy in type 1 diabetes mellitus	11
Low fasting glucose‐to‐estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes	11
Extracellular vesicles from adipose‐derived mesenchymal stem cells prevent high glucose‐induced retinal ganglion cell pyroptosis through a microRNA‐26a‐5p‐dependent mechanism	11
Issue Information	11
Serum metabolomics signature of maternally inherited diabetes and deafness by gas chromatography–time of flight mass spectrometry	11
Factors associated with bleeding complications in patients with coronavirus disease 2019 admitted to intensive care units: A multicenter retrospective cohort study	11
Characterization of the visually impaired patients with diabetes mellitus in Japan	11
HbA1c, blood pressure, and cholesterol control in adults with diabetes: A report card for Kuwait	11
Accelerating innovation and ensuring the thoughtful withdrawal of lifeline medicines for people living with diabetes in Asia	11
Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese pati	11
Adipocyte exosome miR‐4472 inhibits glucose uptake in skeletal muscle through downregulation of MEF2D	10
Lipid signature changes of women with gestational diabetes mellitus in response to puerperal exclusive breastfeeding	10
Association between fat mass index, fat‐free mass index and hemoglobin A1c in a Japanese population: The Tohoku Medical Megabank Community‐based Cohort Study	10
Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy	10
Insulin allergy manifesting soon after COVID‐19 vaccination (BNT162b2)	10
Carotid atherosclerosis: An independent risk factor for small fiber nerve dysfunction in patients with type 2 diabetes mellitus	10
Effects of nutrient metabolism on pancreatic β‐cell mass and function: Recent findings	10
Relationship between nerve ultrasonography image and electrophysiology in diabetic polyneuropathy	10
Commentary on glucose reduction in type 2 diabetes (GRADE)	10
Longitudinal effects of one‐leg standing time on neuropathy outcomes in association with glycemic control in non‐elderly patients with type 2 diabetes	10
Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes	10
Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South‐East Asian countries: Results from the Canagliflozin and Renal Events in D	10
Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo	10
Comment on a recent article titled ‘Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia’	10
Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial	10
The PKM2 activator TEPP‐46 suppresses cellular senescence in hydrogen peroxide‐induced proximal tubular cells and kidney fibrosis in CD‐1db/db	9
Immediate effect of textured insoles on the balance in patients with diabetic neuropathy	9
High HOMA2‐B: A novel risk factor for diabetic peripheral neuropathy beyond metabolic syndrome components in type 2 diabetes	9
Immunoglobulin heavy constant gamma 1 silencing decreases tonicity‐responsive enhancer‐binding protein expression to alleviate diabetic nephropathy	9
Response to Commentary on ‘Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients’	9
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate	9
Improving diagnostic accuracy of 3 Screen ICA ELISA kit in the identification of Japanese type 1 diabetes	9
Neonatal diabetes mellitus around the world: Update 2024	9
Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes	9
Program at a Glance	9
Construction and validation of nomogram prediction model for ketoacidosis in elderly diabetic patients based on baseline data and glycolipid metabolism	9
Pancreatic beta‐cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes	9
Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real‐world data from pharmacies in Japan	9
Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment	9
Neurodevelopmental delay up to the age of 4 years in infants born to women with gestational diabetes mellitus: The Japan Environment and Children's Study	9
Machine learning‐based risk prediction model for neuropathic foot ulcers in patients with diabetic peripheral neuropathy	9
YY2 mediates transcriptional repression of PHGDH and expedites oxidative stress in retinal pigment epithelial cells in diabetic retinopathy	9
Low‐carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials	9
Value of machine learning algorithms for predicting diabetes risk: A subset analysis from a real‐world retrospective cohort study	9
Characteristics of subjects with type 2 diabetes enrolled in randomized controlled trials and non‐randomized controlled trials in Japan: A systematic review	9
Onset of fulminant type 1 diabetes mellitus following hypophysitis after discontinuation of combined immunotherapy. A case report	8
	8
Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes	8
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators	8
Reply to the comments of Saleh et al. on “Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in old‐old patients with diabetes: Is there an association?”	8
Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual‐like protein 1 and acyl‐coenzyme A synthetase l	8
Cognitive protection of incretin‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies	8
Case of type 2 diabetes mellitus with edema resulting in subcutaneous insulin resistance syndrome	8
	8

	8
Longitudinal trends in dementia prevalence among individuals with type 2 diabetes in Taiwan (2009–2022)	8
Elucidation of the clinical traits of diabetic chorea through a questionnaire survey of people with diabetic chorea from 59 Japanese hospitals	8
Progressive loss of corneal nerve fibers is associated with physical inactivity and glucose lowering medication associated with weight gain in type 2 diabetes	8
Oral fat tolerance testing identifies abnormal pancreatic β‐cell function and insulin resistance in individuals with normal glucose tolerance	8
Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data	8
Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A meta‐analysis	8
Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post‐hoc analysis of a prospective and multicen	8
Induction of proximal tubular proliferation and lengthening in response to sodium glucose linked cotransporter‐2 inhibition in experimental rats	8
Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese p	8
Epidemiological characteristics of diabetic kidney disease in Taiwan	8
The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis	8
Cholesterol efflux capacity of high‐density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus	8
Factors associated with the degree of glycemic deterioration among patients with type 2 diabetes who dropped out of diabetes care: A longitudinal analysis using medical claims and health checkup data	7
Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study	7
Decreased serum musclin concentration is independently associated with the high prevalence of sarcopenia in Chinese middle‐elderly patients with type 2 diabetes mellitus	7
Association between maternal gestational diabetes mellitus and high‐sensitivity C‐reactive protein levels in 8‐year‐old children: The Yamanashi Adjunct Study of the Japan Environment and Children’s St	7
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia	7
miR‐31 ameliorates type 2 diabetic vascular damage through up‐regulation of hypoxia‐inducible factor‐1α/vascular endothelial growth factor‐A	7
CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy	7
Reimagining care for young adults living with type 1 diabetes	7
Application of weighted gene co‐expression network analysis to identify novel key genes in diabetic nephropathy	7
Issue Information	7
Development of type 1 diabetes in a patient treated with anti‐interleukin‐6 receptor antibody for rheumatoid arthritis	7
Commentary on “Effectiveness of tele‐guidance for physiotherapy in older patients with type 2 diabetes: A randomized controlled trial”	7
High prevalence of depressive symptoms among people with pediatric‐onset and adolescent‐onset type 1 diabetes: A cross‐sectional analysis of the Diabetes Study from the Center of Tokyo Women's Medical	7
Comparison of the effects of frequent versus conventional nutritional interventions in patients with type 2 diabetes mellitus: A randomized, controlled trial	7
Effects of intermittent very‐low calorie diet on glycemic control and cardiovascular risk factors in obese patients with type 2 diabetes mellitus: A randomized controlled trial	7
Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes	7
Metabolic associated fatty liver disease is a risk factor for chronic kidney disease	7
Corneal confocal microscopy: A useful tool for diagnosis of small fiber neuropathy in type 2 diabetes	7
Association between early‐stage diabetic nephropathy and the delayed monophasic glucose peak during oral glucose tolerance test in type 2 diabetes mellitus	7
Clinical features and sulfonylurea usage among outpatients with diabetes aged ≥90 years in an urban diabetes clinic in Tokyo	7
Biomedical outcomes and cardiovascular risks in Chinese adults with type 2 diabetes in the metabolic management center program: A longitudinal comparative study	7
Correlation of dehydroepiandrosterone with diabetic nephropathy and its clinical value in early detection	7
Relationship between onset age of type 2 diabetes mellitus and vascular complications based on propensity score matching analysis	7
Modification effect of receipt of diabetes care on the association between COVID‐19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide	7
Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy‐proven diabetic kidney disease: A multicenter cohort study	7
Issue Information	6
Trends of severe hypoglycemia in patients with type 2 diabetes in Korea: A longitudinal nationwide cohort study	6
Elevated small dense low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in C	6
Pontine lesion in hyperglycemic crises: Relevance to osmotic demyelination syndrome and posterior reversible encephalopathy syndrome	6
Issue Information	6
Time in range assessed by capillary blood glucose in relation to insulin sensitivity and β‐cell function in patients with type 2 diabetes mellitus: A cross‐sectional study in Chi	6
Issue Information	6
Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease	6
Role of β‐cell autophagy in β‐cell physiology and the development of diabetes	6
Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus	6
Acute kidney injury in Japanese type 2 diabetes patients receiving sodium–glucose cotransporter 2 inhibitors: A nationwide cohort study	6
Association between serum uric acid‐to‐high‐density lipoprotein cholesterol ratio and insulin resistance in an American population: A population‐based analysis	6
LINC01705 derived from adipocyte exosomes regulates hepatocyte lipid accumulation via an miR‐552‐3p/LXR axis	6
Renoprotective effect of additional sodium–glucose cotransporter 2 inhibitor therapy in type 2 diabetes patients with rapid decline and preserved renal function	6
Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events	6
Issue Information	6
Implementation of diabetes care and educational program via telemedicine in patients with COVID‐19 in home isolation in Thailand: A real‐worldexperience	6
Corrigendum	6
β cell replacement therapy for the cure of diabetes	6
Werner syndrome presenting as early‐onset diabetes: A case report	6
Effect of intensive lifestyle intervention on the association between weight variability and major adverse cardiovascular events in overweight or obese adults with type 2 diabetes mellitus	6
Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study	6
Gaps in the management of diabetes in Asia: A need for improved awareness and strategies in men's sexual health	6
	6
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan	6
Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 dia	6
Precision diabetes: Lessons learned from maturity‐onset diabetes of the young (MODY)	6
Issue Information	6
Pregestational diabetes mediates the association between maternal obesity and the risk of congenital heart defects	6
Evolution and diabetic vasculopathy	6
A case of polyneuropathy associated with diabetic ketoacidosis in new‐onset type 1 diabetes	6
Cardiovascular disease in patients with type 2 diabetes	6
Fighting the uphill battle to cure type 1 diabetes	6
Eating behaviors and incidence of type 2 diabetes in Japanese people: The population‐based Panasonic cohort study 15	6
Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus	6
Impact of coexisting diabetes on survival and risk of developing second primary cancer in diabetes patients receiving drug therapy: A multicenter retrospective cohort study of patients with cancer in	5
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials	5
Long non‐coding ribonucleic acid zinc finger E‐box binding homeobox 1 antisense RNA 1 regulates myocardial fibrosis in diabetes through the Hippo–Yes‐associated protein signaling pathway	5
Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals	5
Regulation of food intake by intestinal hormones in brain	5
Plasma cytokines during pregnancy provide insight into the risk of diabetes in the gestational diabetes risk group	5
Effect of intermittent fasting 16:8 and 14:10 compared with control‐group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial	5
Artificial intelligence‐based body composition analysis using computed tomography images predicts both prevalence and incidence of diabetes mellitus	5
Fasting plasma glucose level in the range of 90–99 mg/dL and the risk of the onset of type 2 diabetes: Population‐based Panasonic cohort study 2	5
Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients	5
Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study	5
Clinical significance of small dense low‐density lipoprotein cholesterol measurement in type 2 diabetes	5
	5
	5
	5
The cholesterol‐HDL‐glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy	5
Clinical signs of type 1 diabetes are associated with type 2 diabetes marker transcription factor 7‐like 2 polymorphism	5
Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus	5
Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes	5
The roles of output clock genes in regulating glucose metabolism	5
Issue Information	5
Overview	5